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Peroxisome biogenesis disorders (PBDs) such as Zellweger syndrome (ZS) and neonatal adrenoleukodystrophy are
autosomal recessive diseases caused by defects in peroxisome assembly, for which 13 genotypes have been identified.
Expression of the human peroxin Pex3p cDNA encoding a 373-amino-acid peroxisomal membrane protein mor-
phologically and biochemically restored peroxisome biogenesis, including peroxisomal membrane assembly, in
fibroblasts from PBDG-02, a patient with complementation group G (CG-G) ZS. Patient PBDG-02 carried a
homozygous, inactivating mutation—a 97-bp deletion of nucleotide residues at positions 942–1038—resulting in
a 32-amino-acid truncation and in a frameshift inducing both a 3-amino-acid substitution and a termination codon.
Genomic PCR analysis revealed mutation of TrG at eight bases upstream of the splicing site at the boundary of
intron 10 and exon 11 of PEX3 gene, giving rise to a deletion of all of exon 11. When assessed by expression in
a pex3 mutant of Chinese hamster ovary cells and the patient’s fibroblasts, PBDG-02–derived PEX3 cDNA was
found to be defective in peroxisome-restoring activity. These results provide evidence thatPEX3 is a novel, pathogenic
gene responsible for CG-G PBDs.
Peroxisomes function in various metabolic pathways,
including b-oxidation of very-long-chain fatty acids and
synthesis of ether lipids (van den Bosch et al. 1992).
Human fatal genetic peroxisomal biogenesis disor-
ders (PBDs) include Zellweger syndrome (ZS [MIM
214100]), neonatal adrenoleukodystrophy (NALD), in-
fantile Refsum disease (IRD), and rhizomelic chondro-
dysplasia punctata (RCDP) (Lazarow and Moser 1995).
The primary cause of the peroxisome deficiency in PBDs,
comprised of 13 complementation groups (CGs) (Ki-
noshita et al. 1998; Shimozawa et al. 1998; Ghaedi et
al. 1999), is a failure in peroxisome biogenesis (Brav-
erman et al. 1995; Subramani 1997; Fujiki 2000). Ge-
netic heterogeneities containing 115 CGs have been
identified in mammals, having been determined by use
of fibroblasts from patients with PBDs and of peroxi-
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some-deficient Chinese hamster ovary (CHO) cell mu-
tants (Ghaedi et al. 1999; Fujiki 2000) (see table 1). To
date, 10 PEX genes have been shown to be pathogenic
for 10 CGs of PBDs; several genes have yet to be iden-
tified (Fujiki 2000). Much knowledge of peroxisome bi-
ogenesis has been gained on the basis of findings of to-
pogenic signals and peroxins required for peroxisomal
protein import. However, thoroughly molecular mech-
anisms involved in assembly of peroxisomal membrane
vesicles have yet to be defined. In most CGs, fibroblasts
from patients with PBDs contain morphologically rec-
ognizable peroxisomal membrane remnants, which im-
plies that membrane biogenesis is normal, despite the
impaired import of matrix proteins (Santos et al. 1992;
Wendland and Subramani 1993; Shimozawa et al.
1998). In contrast, in three CGs—CG-D (CG9 in the
United States), CG-G, and CG-J—fibroblasts from pa-
tients with PBDs are absent from peroxisomal remnants,
and are thus indicative of apparent defects in peroxisome
membrane assembly (Kinoshita et al. 1998; Shimozawa
et al. 1998). PEX16 (Honsho et al. 1998; South and
Gould 1999) and PEX19 (Matsuzono et al. 1999) were
shown to be responsible for PBDs of CG-D and CG-J,
respectively. Using ZPG208, a CHO cell mutant deficient
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Table 1
Complementation Groups of Patients with PBDs and CHO Cell Mutants
CG DESIGNATION OF
PATIENTS WITH PBDs
PHENOTYPE CHO MUTANT
PEROXISOMAL
GHOSTSa GENEJapanese U.S./European
G ZS ZPG208  PEX3
A 8 ZS, NALD, IRD ZP124 
B 7(5)b ZS, NALD  PEX10
C 4 ZS, NALD ZP92  PEX6
D 9 ZS  PEX16
E 1 ZS, NALD, IRD Z24/ZP107  PEX1
F 10 ZS, IRD Z65  PEX2
H 13 ZS, NALD ZP128  PEX13
J ZS ZP119  PEX19
2 ZS, NALD ZP105/ZP139  PEX5
3 ZS, NALD, IRD ZP109  PEX12
6 ZS, NALD 
R 11 RCDP ZPG207  PEX7
ZP110  PEX14
ZP114 
ZP126 
a A plus sign () denotes that peroxisomal remnants (ghosts) are present; a minus sign () denotes
that they are absent.
b From the study by Shimozawa et al. (1998)
in peroxisome assembly, we cloned rat PEX3 cDNA by
genetic phenotype-complementation assay (Ghaedi et al.
2000). We now report that human PEX3 (HsPEX3
[MIM 603164]) complements the impaired peroxisome
biogenesis in fibroblasts devoid of peroxisomal mem-
brane vesicles from a patient with CG-G PBD.
Fibroblasts from PBDG-02, a patient with CG-G ZS,
showed a diffused, cytosolic localization of catalase,
which is indicative of peroxisome deficiency, as veri-
fied by cell staining with an anticatalase antibody (Shi-
mozawa et al. 1992) (see fig. 1A, subpanel b). When
PBDG-02’s fibroblasts were fused with the CHO pex3
mutant ZPG208 (Ghaedi et al. 2000), the impaired pro-
tein import was not restored (data not shown), which
demonstrates that PBDG-02’s cells are in the same CG
as is ZPG208 (table 1). Peroxisomal remnants, so-called
ghosts, were not discernible in PBDG-02’s fibroblasts
(table 1), as assessed by cell staining with antibody to
70-kD peroxisomal membrane protein (PMP70) (not
shown), thereby confirming a defect in peroxisome
membrane biogenesis. These results collectively show
that PBDG-02’s cells are impaired in biogenesis of not
only soluble proteins but also membrane polypeptides,
an impairment most likely caused by a defect in PEX3.
HsPEX3 expression indeed complemented impaired im-
port of catalase (fig. 1A, subpanel a) and of peroxisome-
targeting signal type I (PTS1) proteins, as well as 3-
ketoacyl-CoA thiolase, a PTS2-protein (data not shown),
in PBDG-02’s fibroblasts. PMP70-positive peroxisomes
were also observed, in a superimposable manner, with
peroxisomes stained by use of anticatalase antibody (not
shown). Therefore, Pex3p could morphologically restore
peroxisome assembly in PBDG-02’s fibroblasts.
We next verified the biogenesis of peroxisomal pro-
teins in CG-G fibroblasts. PMP70 was not discernible
in PBDG-02’s fibroblasts (fig. 2, top panel, lane 2), pre-
sumably because of a rapid degradation, as seen in the
CHO pex19 mutant ZP119 (Kinoshita et al. 1998), al-
though PMP70 was detectable in normal fibroblasts
(lane 1). When PBDG-02’s fibroblasts were transient-
ly transfected with HsPEX3, PMP70 was detected, as
in normal cells (lane 3), indicating that the impaired
biogenesis of PMP70 was restored. On transfection of
HsPEX3, Pex3p was also detectable, albeit at a low
level, when anti-C-terminal Pex3p peptide antibody was
used (Ghaedi et al. 2000), thereby confirming the ex-
pression of HsPex3p, whereas Pex3p was not discernible
in PBDG-02’s fibroblasts (data not shown). Peroxisomal
3-ketoacyl-CoA thiolase of fatty acid b-oxidation system
is synthesized as a larger, 44-kD precursor with an
amino-terminal, cleavable PTS2 and is processed to 41-
kD mature form in peroxisomes (Tsukamoto et al.
1990). In normal fibroblasts, only the matured thiolase
was detected (fig. 2, middle panel, lane 1), thereby pro-
viding evidence for a rapid processing of the precursor
form. In PBDG-02’s cells, the larger precursor was not
detectable (fig. 2, middle panel, lane 2), presumably be-
cause of degradation. When PBDG-02’s fibroblasts were
transiently transfected with HsPEX3, the mature thio-
lase was clearly discerned (fig. 2, middle panel, lane 3).
A PTS1 protein, acyl-CoA oxidase (AOx), is synthesized
as a 75-kD polypeptide (A component) and is proteo-
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Figure 1 Impaired PEX3 in a patient with CG-G ZS. A, Expression of HsPEX3, which restores peroxisome assembly. HsPEX3 and flag-
tagged PEX3delEx11 derived from PBDG-02 (see fig. 1B) were separately expressed in PBDG-02’s fibroblasts (a and b); flag-tagged HsPEX3
and flag-tagged PEX3delEx11 were transfected into pex3 ZPG208 cells (c and d). Cell staining was done by use of primary rabbit antibodies
to catalase (a and b) and PMP70 (c and d) and of a secondary Texas Red–labeled sheep anti-rabbit immunoglobulin G antibody. In b, the scale
bar (which also applies to a) p 40 mm; in d, the scale bar (which also applies to c) p 20 mm. Note that peroxisomes were restored in (a and
c) but not in (b and d). B, Mutation analysis of PEX3 from a patient with CG-G ZS, PBDG-02. Partial nucleotide sequence and the deduced
amino acid sequence of PEX3 cDNA isolated from a normal control (upper-left panel) and PBDG02 (lower-left panel) are shown. A 97-bp
deletion of nucleotide residues 942–1038 (boxed) was identified. PCR was also done for DNA from a normal control (upper-right panel) and
from PBDG-02’s fibroblasts (lower-right panel); the nucleotide sequence of PCR products was determined. Only partial sequence at the boundary
of intron 10 and exon 11 is shown; a codon for Leu315 is underlined in the sequence of the normal control.
lytically converted into 53- and 22-kD polypeptides (B
and C components, respectively) in peroxisomes (Tsu-
kamoto et al. 1990). All three polypeptide components
were evident in normal fibroblasts from a control (fig.
2, bottom panel, lane 1), whereas they were barely de-
tectable in PBDG-02’s cells (fig. 2, bottom panel, lane
2), possibly reflecting the occasional peroxisome-positive
cell and degradation of most of AOx-A (Tsukamoto et
al. 1990; Ghaedi et al. 1999). When PBDG-02’s cells
were transfected with HsPEX3, the three components
of AOx were detected at a distinct level, indicative of
proper import and proteolytic conversion of AOx (fig.
2, bottom panel, lane 3). These results demonstrate that
HsPEX3 can complement the impaired biogenesis of
peroxisomal proteins in PBDG-02’s cells. HsPEX3 ex-
pression restored peroxisome biogenesis only in the
CHO pex3 mutants (Ghaedi et al. 2000) (see fig. 1A,
subpanel c) in 13 CGs of peroxisome-deficient CHO cell
mutants, where the CHO mutants of 10 CGs represent
PBD CGs (Tsukamoto et al. 1990; Shimozawa et al.
1992; Kinoshita et al. 1998; Ghaedi et al. 1999; Toyama
et al. 1999) (table 1). Taken together, these observations
confirm that Pex3p is a peroxisome biogenesis factor for
CG-G PBD. Therefore, PEX3 is the 11th gene identified
as being responsible for peroxisome-deficiency diseases.
Both to isolate PEX3 cDNA from PBDG-02’s fibro-
blasts and to determine the PEX3 dysfunction, we
conducted reverse transcription–PCR (RT-PCR), using
poly(A)RNA and a pair of HsPEX3-specific PCRprim-
ers: a sense HsPEX3-BamF (5′-TAAGCTTGAGATCTT-
GAGGTCTGTATGGA-3′) and an antisense HsPEX3-
ApaR (5′-GGGTACCGGGCCCTCATTTCTCCAGTT-
GC-3′) (where the termination codon is underlined), as
described elsewhere (Honsho et al. 1998). Subsequent
sequencing of cDNA clones by the dideoxy-chain ter-
mination method indicated a 97-bp deletion of nucle-
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Figure 2 Complementation of biogenesis of peroxisomal pro-
teins. Cell lysates ( cells) were subjected to SDS-PAGE and5∼ 2# 10
were transferred to polyvinylidene difluoride membrane. Immunoblot
analysis was done by use of rabbit antibodies to PMP70 (top), thiolase
(middle), and AOx (bottom) and an ECL western-blotting detection
reagent. Lane 1, Normal control fibroblasts. Lane 2, PBDG-02’s fi-
broblasts. Lane 3, PBDG-02’s fibroblasts transiently transfected with
HsPEX3. Unblackened and blackened arrowheads indicate PMP70
and a mature form of thiolase, respectively; arrows indicate AOx com-
ponents A–C. Dots indicate nonspecific bands (Kinoshita et al. 1998;
Tamura et al. 1998).
otide residues at positions 942–1038, resulting in a 32-
amino-acid truncation and a frameshift inducing a
3-amino-acid substitution and a termination codon (fig.
1B, left). This truncated part corresponded exactly to
exon 11 of the HsPEX3 gene (Muntau et al. 2000).
Fifteen of the isolated PEX3 cDNA clones, termed
“PEX3delEx11,” all carried the same mutation, thereby
suggesting a homozygous event causing a defective splic-
ing. To search for both a mutation site in the intron and
zygosity of a PEX3delEx11 mutant allele, genomic PCR
with a pair of PEX3-specific primers—forward primer
Ex11-104–133F (5′-TCACAGCTAGAGGACAGATTA-
CTGTATAGT-3′) and reverse primer Ex11-711–737R
(5′-TGCTATGGTCCGTTATTACTCTCATGG-3′)—was
used to amplify the sequence between residues 104 and
737, encompassing 361 nucleotide residues on the 3′ side
of intron 10, the 97 nucleotides of exon 11, and 176
nucleotides on the 5′ side of intron 11 in the HsPEX3
gene (GenBank accession number AJ009873) (Muntau
et al. 2000). In seven independent clones isolated from
PCR products, we identified a single type of nucleotide
sequence, which, apparently, gave rise to a deletion of
exon 11: T was mutated to G at eight bases upstream
of the splicing site at the boundary of intron 10 and
exon 11 (fig. 1B, right). These observations were inter-
preted to mean that patient PBDG-02, who has ZS, was
a homozygote for the TrG mutation, causing the de-
letion of exon 11. This homozygosity may be explained
by this patient’s history, since PBDG-02 was the third
child of consanguineous Italian parents (Poulos et al.
1995). This mutation inactivated the function of PEX3,
as verified by expression of flag-PEX3delEx11 in PBDG-
02’s fibroblasts and in pex3 ZPG208 cells of the same
CG, where peroxisomes were not formed, as assessed by
staining of catalase and PMP70, respectively (fig. 1A,
subpanels b and d). Normal flag-HsPEX3 restored per-
oxisome assembly in ZPG208 (fig. 1A, subpanel c), as
well as in PBDG-02’s fibroblasts (not shown), indicating
that flag tagging did not interfere with Pex3p function.
The data collectively indicate that mutation of PEX3 is
the genetic-related cause of CG-G PBDs.Moreover, these
findings show the importance that the C-terminal area
of Pex3p has for biological activity.
We also investigated the kinetics of peroxisome assem-
bly, with respect to both membrane vesicle formation and
soluble-protein import. PBDG-02’s fibroblastswere trans-
fected with HsPEX3 and were monitored for peroxisome
biogenesis, at various time points, by our visualizing of
several endogenous peroxisomal proteins, including the
membrane peroxin Pex14p—a convergent component of
a potential import machinery (Shimizu et al. 1999; Otera
et al. 2000)—and PMP70, as well asmatrix proteins PTS1
and catalase. We observed that peroxisomal membrane
vesicles were apparently formed prior to the import of
matrix proteins (data not shown), in agreement with the
findings for the CHO pex3 mutant ZPG208 (Ghaedi et
al. 2000). Therefore, Pex3p is most likely to be involved
in peroxisome assembly at the early stage of peroxisomal
membrane vesicle formation.Mammalian Pex3p interacts
with Pex19p (Soukupova et al. 1999; Ghaedi et al. 2000;
Sacksteder et al. 2000). It is likely that Pex3p functions
as a peroxisome biogenesis factor, possibly by interacting
with other PEX proteins as well (Soukupova et al. 1999;
Ghaedi et al. 2000; Sacksteder et al. 2000). The precise
mechanisms by which Pex3p functions in peroxisome
membrane assembly remain to be defined.
We had previously cloned mammalian PEX3 cDNAs
by functional phenotype-complementation assay, using
CHO cell mutants (Ghaedi et al. 2000). In that report,
we had concluded that PEX3 expression could not com-
plement fibroblasts from PBDG-02 (who, in that report,
was designated “CG-G patient 2”) (Ghaedi et al. 2000).
We observed that PBDG-02’s fibroblasts are unstablewith
respect to peroxisome deficiency: peroxisomes, including
peroxisomal remnants, emerge either occasionally or
readily, depending on cell-culture conditions such as con-
secutive cell-culture passages. Moreover, cell growth rate
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varies significantly. The main reason for the conclusion
in our earlier report appears to have been the following:
cell-doubling time was 14 d, and phenotype complemen-
tation was verified 4 d after PEX3 transfection (Ghaedi
et al. 2000)—whereas the cell-doubling time in the present
study was 1.5 d, and peroxisome restoration was mostly
assessed 5 d after HsPEX3 transfection. In the present
work, we selected, from several different lots of stocks
that had been prepared at various times of cell passage,
one cell stock showing a better, typical mutant phenotype.
For a more prolonged time after transfection of HsPEX3,
we observed cells for phenotype complementation; for cell
mutants, including patients’ fibroblasts, we did not find
that cell-culture conditions resulted in such a difference
in morphological phenotype. Possibly because of differ-
ences in cell growth rate, the kinetics of peroxisome as-
sembly apparently vary, depending on the genotype of
115 CGs of impaired peroxisome biogenesis in mammals.
To what extent such differentiated peroxisome assembly
is relevant to the severity of PBDs is, at present, unclear.
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